NDC 0338-7112 - TISSEEL Fibrin Sealant
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-7112
- Package NDCs from labels
- 0338-7112-01, 0338-7112-02, 0338-7112-05
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2025-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TISSEEL Fibrin Sealant - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2025-09-30 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-7112-01 | TISSEELFibrin Sealant | 1 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 1 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-01 | TISSEELFibrin Sealant | 1 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 1 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-02 | TISSEELFibrin Sealant | 2 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 2 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-02 | TISSEELFibrin Sealant | 2 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 2 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-05 | TISSEELFibrin Sealant | 5 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 5 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-05 | TISSEELFibrin Sealant | 5 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 5 mL | 86.5 mg in 1mL | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0338-7112 | TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) KIT TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 | Unmatched | 20240802_b3f69e25-1b87-4507-81fa-582ea084673d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Natrium Muriaticum 6X | SODIUM CHLORIDE | Seroyal USA | 0ebf18de-12fe-0bc4-e054-00144ff88e88 | 2022-07-07 | Warnings | 451W47IQ8X |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
| Erogetone | ARALIA QUINQUEFOLIA, BERBERIS VULGARIS, CAUSTICUM, CONIUM MACULATUM, DAMIANA, GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SEPIA | Energique, Inc. | 1e872ecd-e7a5-463d-9832-47b7046096db | 2022-06-28 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Cardioplegic Solution | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Fresenius Kabi, USA, LLC | eb360dc4-88d6-4b28-9b61-bc359e16bd22 | 2022-05-27 | Warnings, Adverse reactions | 451W47IQ8X M4I0D6VV5M |
| Calcarea Muriatica | CALCAREA MURIATICA | Hahnemann Laboratories, INC. | df517477-164b-33cc-e053-2a95a90a2083 | 2022-05-18 | M4I0D6VV5M | |
| Bio Co-Enzyme Phase | BETA VULGARIS, ASCORBICUM ACIDUM, CYSTEINUM, NATRUM OXALACETICUM, NICOTINAMIDUM, PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CERIUM OXALICUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, NADIDUM, NATRUM PYRUVICUM, PANTOTHENIC ACID, SUCCINICUM ACIDUM, ADRENALINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, HEPAR SULPHURIS CALCAREUM, SULPHUR, ACONITICUM ACIDUM, CIS-, | Deseret Biologicals, Inc. | e8f6e2ec-ae2e-4bee-b9d3-5f3a2e3daf65 | 2022-05-09 | Warnings | 25X51I8RD4 |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | B22547B95K | |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | 24a08a93-df23-474b-873e-c59ec8855f9f | 2022-03-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Wild Horse 777 Moisturizing Nasal | SODIUM CHLORIDE | Wild Horse 777, Inc. | b0b4dadd-11fa-3dbb-e053-2995a90a2097 | 2022-03-14 | Warnings | 451W47IQ8X |
| FOASU Pink Y s RecoveryCream | NIACINAMIDE, ADENOSINE | HANSCOS Co.,Ltd. | d8fa2f3f-52e1-47ef-e053-2995a90a2a94 | 2022-02-27 | Warnings | 25X51I8RD4 |
| FOASU Pink Y s Collagen Moisturizing Mask | NIACINAMIDE, ADENOSINE | HANSCOS Co.,Ltd. | d8faaf8e-180d-4255-e053-2a95a90aab32 | 2022-02-27 | Warnings | 25X51I8RD4 |
| FOASU Pink Y s MOISTURIZING MIST | NIACINAMIDE, ADENOSINE | HANSCOS Co.,Ltd. | d8f899ea-4665-979d-e053-2a95a90abcf4 | 2022-02-26 | Warnings | 25X51I8RD4 |
| FOASU JIN MOISTURIZING ESSENCE | NIACINAMIDE, ADENOSINE | HANSCOS Co.,Ltd. | d8f9c89e-dbae-3967-e053-2a95a90a7363 | 2022-02-26 | Warnings | 25X51I8RD4 |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | cc14fafd-3dcd-4fc8-bdbd-6f355c375768 | 2022-02-23 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 8b44bfd3-70a4-4b47-bc7b-590f63b8cc75 | 2022-02-15 | Warnings, Adverse reactions | 451W47IQ8X |
| ACNE HP | CARBO ANIMALIS, ACTIVATED CHARCOAL, POTASSIUM DICHROMATE, SODIUM CHLORIDE, PULSATILLA VULGARIS, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE, SULFUR, ZINC | Natural Creations, Inc. | b2368ab6-e233-4473-99fa-86e1fbc2a879 | 2022-02-14 | Warnings | 451W47IQ8X |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | a63da38d-1fea-4ee0-a70b-55c891a5ebcc | 2022-02-11 | B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | ac8971a9-36d0-43c9-9121-ba5e58c28bed | 2022-02-11 | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.